|Year : 2017 | Volume
| Issue : 1 | Page : 117-120
Comparative study of the effect of intravenous paracetamol and tramadol in relieving of postoperative pain after general anesthesia in nephrectomy patients
Venkata Sesha Sai Krishna Manne, Srinivasa Rao Gondi
Department of Anaesthesia, NRI Medical College and Hospital, Guntur, Andhra Pradesh, India
|Date of Web Publication||16-Feb-2017|
Dr. Venkata Sesha Sai Krishna Manne
Saibaba Road, D. No. 4-21-5, Chaitanyapuri 1st Line, Guntur - 522 007, Andhra Pradesh
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Aim: The aim of this study was to compare the effect of intravenous paracetamol and tramadol in relieving of postoperative pain after general anesthesia for nephrectomy in prospective donor patients for kidney transplantation. Materials and Methods: A randomized study was conducted on 100 adult patients scheduled for nephrectomy aged from 35 to 55 years of both sexes and divided into two groups and were administered intravenous paracetamol and tramadol for postoperative pain relief and assessed with visual analog scale score and variations in vital parameters to assess extent of pain relief. Results: After statistical interpretation of collected data, the observations were extrapolated. There was a statistically significant difference in the pain intensity scores obtained between the paracetamol and tramadol groups. Conclusion: On the basis of the present study, it is concluded that tramadol due to its lesser onset of action time was superior to paracetamol in providing acute postoperative pain relief.
Keywords: Paracetamol, postoperative pain, tramadol
|How to cite this article:|
Manne VS, Gondi SR. Comparative study of the effect of intravenous paracetamol and tramadol in relieving of postoperative pain after general anesthesia in nephrectomy patients. Anesth Essays Res 2017;11:117-20
|How to cite this URL:|
Manne VS, Gondi SR. Comparative study of the effect of intravenous paracetamol and tramadol in relieving of postoperative pain after general anesthesia in nephrectomy patients. Anesth Essays Res [serial online] 2017 [cited 2022 Aug 16];11:117-20. Available from: https://www.aeronline.org/text.asp?2017/11/1/117/186619
| Introduction|| |
The International Association for the Study of Pain has defined pain as an unpleasant sensory and emotional experience associated with actual or potential tissue damage or describe in terms of such damage.
Sherrington in 1906 defined pain as “the physical adjunct to an imperative protective reflex.”
The incidence of postoperative pain varies individually and is related to site and type of surgery.
A major physical trauma is being faced by the kidney donors in view of postoperative pain and discomfort in the convalescence period.,,,,,
The opioids and nonsteroidal anti-inflammatory drugs (NSAIDS) that are being used for decades have many side effects such as postoperative nausea and vomiting, respiratory depression, sedation, and renal injury.
The intravenous paracetamol is a nonopioid analgesic which is well tolerated and acts on central nervous system by way of central cyclooxygenase inhibition.
After the approval of intravenous paracetamol (acetaminophen) in 2010, it has been widely used for fever and pain in children and adults.
Like many NSAIDS, it does not interfere with platelet or kidney function.
Tramadol is a synthetic opioid belonging to the aminocyclohexanol group and has weak opioid against properties and central analgesic action.
As both of the drugs have minimal effects on kidneys, this prospective, randomized double-blinded study was done to compare intravenous paracetamol with tramadol in live donor nephrectomies for kidney transplantation.
Our aim to assess statistically for difference in visual analog scale (VAS) score and vital parameters which reflect the pain relief in the postoperative period in the two groups of patients receiving tramadol and paracetamol.
| Materials and Methods|| |
After approval from the Institutional Ethics Committee and written informed consent from the patient, a randomized study was conducted on 100 adult patients of American Society of Anesthesiologists class I and II planned for nephrectomy in prospective donor patients posted for kidney transplantation.
Patients with severe or moderate hemodynamic disturbances with significant renal, hepatic, respiratory diseases, pregnant and lactating women, and patients already suffering with severe pain and using analgesics were excluded from the study.
All the patients irrespective of group to which they belong received tablet alprazolam 0.25 mg on night before the day of surgery.
Before the surgery, patients were explained about the VAS 0–100 of pain, and the pain relief scores. Pulse rate (PR), arterial blood pressure (noninvasive blood pressure), and respiratory rate (RR) were recorded. Patient's age, weight, height, and preoperative investigations were also noted along with vital data.
The patients were randomly divided into two groups of fifty each and administered with the study drugs intravenously in a double-blind fashion 30 min completion of surgery.
- Group I – Received i.v. tramadol 2 mg/kg slow i.v.
- Group II – Received i.v. paracetamol 1 g in 100 ml vital infused over 15 min
- The dose is repeated 6th hourly. The maximum total dose of tramadol was 400 mg/day, and paracetamol was 4 g/day
- Anesthetic protocol was similar for all patients
- Postoperative hemodynamic parameters and pain score using VAS score were evaluated
- Pain intensity was measured based on VAS pain grading that included scores: 0 (no pains), 10 (worse pain)
- VAS was obtained at 0 min, 15 min, 30 min, 1 h, 3 h, 6 h, 12 h, and 24 h
- Postoperative hemodynamic parameters such as HR, systolic blood pressure (SBP), RR, oxygen, and saturation (SpO2) percentage were evaluated at regular intervals at 0 min, 15 min, 30 min, 1 h, 3 h, 6 h, 12 h, and 24 h.
| Observation and Results|| |
Statistical analysis (Chi-square test) was applied to all of the parameters included in the study.
The cases were studied under the following demographic data shown in [Table 1], the patients in the two groups were comparable with respect to the age and weight.
There was statistically significant difference in the pain intensity and pain relief scores obtained between tramadol and paracetamol group [Table 2] and [Table 3].
|Table 2: Postoperative pain intensity in visual analog scale (mean±standard deviation)|
Click here to view
The basal pain scores are similar in both the groups. The onset of analgesia was faster in tramadol group than paracetamol group. In tramadol group, significant decrease pain intensity scores were observed from 15 min onward (P > 0.05) and from 30 min in paracetamol group. The maximum pain relief was observed at 1 h in tramadol group and 3 h in paracetamol group. This statistically significant difference between the two groups was observed up to 24 h (P > 0.05).
The postoperative sedation scores were also compared by Chi-square test [Table 4], and there was a statistically significant difference in sedation scores up to 6 h (P < 0.05).
When the vital parameters were compared between the two groups, there was no statistically significant difference of PR, SBP, RR, and SpO2 between the two groups at all the time intervals (P > 0.05) [Table 5], [Table 6], [Table 7], [Table 8].
|Table 6: Postoperative systolic blood pressure in mmHg (mean±standard deviation)|
Click here to view
|Table 7: Postoperative respiratory rate per minute (mean±standard deviation)|
Click here to view
|Table 8: Postoperative oxygen saturation percentage (mean±standard deviation)|
Click here to view
The adverse effects in the 24 h period postoperatively, namely, nausea, vomiting, and retention of urine were noted in the two groups [Table 9]. The incidence of nausea, vomiting, and retention of urine is more in the tramadol group.
| Discussion|| |
The relief of postoperative pain is a subject which has been receiving an increasing amount of attention in the past few years. Despite recent advances in the understanding of postoperative pain and widespread recognition of the problem, clinical surveys indicate that routine treatment of postoperative pain remains unsatisfactory.
A comprehensive management of postoperative pain results in successful recovery. Various methods and agents used for postoperative analgesia are NSAIDS, ketamine, opioids, PCM, peripheral local anesthetics, and epidural analgesia. PCM belongs to class of drugs known as aniline analgesics. It has both central and peripheral actions. The central action is the inhibition of cyclooxygenase enzyme, and peripheral action is by its metabolite N-acetyl P-benzoquinone imine which acts on transient receptor potential ankyrin receptors in the spinal cord to alleviate pain.,
In our study, we compared i.v. paracetamol and tramadol for postoperative pain relief in nephrectomy patients.
Both groups (paracetamol and tramadol) were found comparable on the basis of age, weight, preoperative investigations, and preoperative hemodynamic parameters.
Postoperative pain relief was measured by VAS score and pain relief scores at 0 min, 15, 30, 60, 3, 6, 12, and 24 h taking value at the immediate postoperative period (0 min) as baseline.
Postoperatively, all patients were monitored with SpO2, PR, BP, and RR for 24 h, and these values were compared to that of baseline values which were recorded is immediate postoperative period (0 min).
The parameters observed were compared statistically and Chi-square test was performed where and when appropriate significance was considered when P < 0.05.
The onset of analgesia is faster in tramadol group. There was a significant decrease in VAS score from 15 min onward, and this was observed up to 3 h.
In paracetamol group, the onset of analgesia was slightly delayed. Pain scores significantly decreased after 60 min, and this was observed up to 6 h and pain scores increased thereafter.
In our study, there were no significant changes in postoperative mean SBP and diastolic blood pressures, PR, RR, and percentage SpO2.
Drowsiness was found to be higher in tramadol group and regarding other side effects in tramadol group, the incidence of nausea was 16% and vomiting in 16% of cases.
| Conclusion|| |
Postoperative analgesia is the key factor of successful recovery from any surgery. From the different parameters compared in our study, both tramadol and paracetamol offer adequate postoperative analgesia. Tramadol due to its quick onset of action and fewer side effects is better than intravenous paracetamol for postoperative analgesia.
The authors wish to thank the operating room personnel and the intensive care nursing staff for their support in this clinical investigation.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Steinhauser MM, Dawson PB, Barshick RM, Janecek JL. Pain experienced by laparoscopic donor nephrectomy patients in an academic medical setting. Prog Transplant 2003;13:117-22.
Freedland SJ, Blanco-Yarosh M, Sun JC, Hale SJ, Elashoff DA, Litwin MS, et al.
Ketorolac-based analgesia improves outcomes for living kidney donors. Transplantation 2002;73:741-5.
Lennerling A, Blohmé I, Ostraat O, Lönroth H, Olausson M, Nyberg G. Laparoscopic or open surgery for living donor nephrectomy. Nephrol Dial Transplant 2001;16:383-6.
Perry KT, Freedland SJ, Hu JC, Phelan MW, Kristo B, Gritsch AH, et al.
Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy. J Urol 2003;169:2018-21.
Ratner LE, Ciseck LJ, Moore RG, Cigarroa FG, Kaufman HS, Kavoussi LR. Laparoscopic live donor nephrectomy. Transplantation 1995;60:1047-9.
Ratner LE, Kavoussi LR, Sroka M, Hiller J, Weber R, Schulam PG, et al.
Laparoscopic assisted live donor nephrectomy – A comparison with the open approach. Transplantation 1997;63:229-33.
Kela M, Umbarkar S, Sarkar M, Garasia M. Comparative study of efficacy of IV paracetamol vs. IV tramadol for postoperative pain relief after cardiac surgery. Bombay Hosp J 2011;53:582-6.
Schug SA, Sidebotham DA, McGuinnety M, Thomas J, Fox L. Acetaminophen as an adjunct to morphine by patient-controlled analgesia in the management of acute postoperative pain. Anesth Analg 1998;87:368-72.
Duggan ST, Scott LJ. Intravenous paracetamol (acetaminophen). Drugs 2009;69:101-13.
Ide S, Minami M, Ishihara K, Uhl GR, Sora I, Ikeda K. Mu opioid receptor-dependent and independent components in effects of tramadol. Neuropharmacology 2006;51:651-8.
Pesut B, Johnson J. Evaluation of an acute pain service. Can J Nurs Adm 1997;10:86-107.
Woolf CJ, Chong MS. Preemptive analgesia – Treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993;77:362-79.
Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: New vistas of an old drug. CNS Drug Rev 2006;12:250-75.
Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al.
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc Natl Acad Sci U S A 2002;99:13926-31.
Andersson DA, Gentry C, Alenmyr L, Killander D, Lewis SE, Andersson A, et al.
TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ(9)-tetrahydrocannabiorcol. Nat Commun 2011;2:551.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7], [Table 8], [Table 9]
|This article has been cited by|
||Comparative study of transperitoneal laparoscopic versus retroperitoneoscopic ureterolithotomy techniques
| ||Sunil Mhaske, Vilas Sabale, Vikram Satav, Sonu Sharma, Shashikant Asabe, Hareesh Belagalli |
| ||Urological Science. 2022; 33(1): 9 |
|[Pubmed] | [DOI]|
||Intravenous paracetamol infusion and tramadol as agents for post operative pain relief in urosurgical patient: A randomized control trial
| ||Nalin Vilochan, Anisha Puri, Arvin Preet Kour, Gurchand Singh, Ajaydeep Singh |
| ||International journal of health sciences. 2022; : 2894 |
|[Pubmed] | [DOI]|
||Review of Intravenous Acetaminophen for Analgesia in the Postoperative Setting
| ||Danielle M. Tompkins, Arielle DiPasquale, Michelle Segovia, Stephen M. Cohn |
| ||The American Surgeon. 2021; : 0003134821 |
|[Pubmed] | [DOI]|